← Company intelligence

Robot maker · registered

Vivodyne

Corporate marketlabCurated record

Vivodyne designs and builds its own fully autonomous robotic lab platform (branded Hive Pro) to grow and test over 10,000 human organ tissues simultaneously with zero human intervention. The proprietary system automates every pipeline step — tissue growth, dosing, sampling, imaging, and data analysis — capturing 60+ billion data points annually. An internal robotics team develops the cutting-edge robotic technology crucial for tissue production at scale. The company sells drug-discovery data and services to pharma, with the robotic platform as the core enabling technology.

HeadquartersSouth San Francisco, US
Founded2022
Corporate funding$40M
TeamNot listed
Deployments0
Open roles0
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StageSeries A
FoundersAndrei Georgescu (Co-founder, CEO), Dan Huh (Co-founder)
Regions servedUS
Countries deployedNot listed
Service footprintNot listed
Last reviewed2026-07-14
MX

Robot models

Specifications remain vendor-claimed

Machinelab

Hive Pro

  • Experiments on 10,000+ human tissues of various types simultaneously with zero human intervention

    Throughput of Vivodyne's proprietary autonomous robotic lab platform

    Claim source
CA

Funding history

Publicly announced rounds

Investors on recordKhosla VenturesCS VenturesBison VenturesMBX CapitalKairos Ventures
TL

Company timeline

Milestones and announcements

2024-01-01Raises $38M seed round led by Khosla Ventures to advance autonomous robotic tissue-testing platformLongevity Technology
SC

Source ledger

2 unique public sources